Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Leptos Biomedical
AddedFeb 17, 2024
UpdatedJun 18, 2026
Leptos Biomedical

Leptos Biomedical

Leptos Biomedical: Pioneering neuromodulation therapy for chronic obesity since 2002.

HQ
San Mateo, CA, US
Founded
2002
Overview
Compare
Fundraising
Employees

Leptos Biomedical, founded in 2002 and based in Fridley, Minnesota, focuses on pioneering neuromodulation therapy for chronic obesity. The company offers a proprietary treatment involving the electrical activation of a nerve in the autonomic nervous system via a pacemaker-type device, aiming to provide an innovative solution for weight management.

Leptos Biomedical has made significant strides in the field of neuromodulation therapy, impacting the lives of individuals struggling with chronic obesity. Its innovative approach and dedication to advancing medical technology have positioned it as a notable player in the healthcare sector.

Leptos Biomedical - Similar Companies

Niche Biomedical logo

Niche Biomedical

NeuroBionics logo

NeuroBionics

EndoMetabolic Solutions logo

EndoMetabolic Solutions

endometabolic.com

Micro-Leads logo

Micro-Leads

Avivomed logo

Avivomed

avivomed.com

Presidio Medical logo

Presidio Medical

RBI Medical logo

RBI Medical

Neuros Medical logo

Neuros Medical

neurosmedical.com

NBI Development logo

NBI Development

Neuspera Medical logo

Neuspera Medical

neuspera.com

Tal Medical logo

Tal Medical

Nevro logo

Nevro

electroCore logo

electroCore

Scion Neurostim logo

Scion Neurostim

scionneurostim.com

NeurAxis logo

NeurAxis

neuraxis.com

Leptos Biomedical - Quick Facts

Who are Leptos Biomedical's competitors?

Companies similar to Leptos Biomedical include Niche Biomedical, NeuroBionics, EndoMetabolic Solutions and Micro-Leads.

When was Leptos Biomedical founded?

Leptos Biomedical was founded in 2002.

Where is Leptos Biomedical's headquarters located?

Leptos Biomedical's headquarters is located in San Mateo, CA, US.

When was Leptos Biomedical's last funding round?

Leptos Biomedical's most recent funding round was for $20M (USD) in August 2007.

How much has Leptos Biomedical raised to-date?

As of Aug 16, 2007, Leptos Biomedical has raised a total of $26M (USD).

How many employees does Leptos Biomedical have?

Leptos Biomedical has 5 employees as of Feb 4, 2024.

Leptos Biomedical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Medical Devices
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Neuromodulation
  • Obesity Treatment
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities